In both the national and regional datasets, the misclassified T1D patients were characterized by younger age, fewer T2D encounters, lower weight and BMI, as well as higher HbA1c values and prevalence of insulin usage, compared to the confirmed T2D patients. This evidence concerns the gene INS and type 2 diabetes mellitus.